# Limited Competition: Clinical and Translational Science Awards (CTSA) Consortium-Wide Centers: Resources for Rapid Demonstration and Dissemination (U24 Clinical Trials Optional)

Source: https://welltoldgrants.com/grants/par-22-122-limited-competition-clinical-and-translational-science/  
Official notice: https://www.grants.gov/search-results-detail/338452

> National Institutes of Health offered grants of up to $3.0 million to state and local governments. Applications closed on January 6, 2023.

| Field | Value |
|---|---|
| Opportunity number | PAR-22-122 |
| Agency | National Institutes of Health |
| Status | Forecast |
| Deadline | January 6, 2023 |
| Award ceiling | $3.0 million |
| Award floor | not stated |
| Expected awards | not stated |
| Total funding | not stated |
| Cost sharing | not required |
| Assistance Listings | 93.350 |

## Who can apply

- Independent school districts
- Public housing authorities/Indian housing authorities
- Others (see text field entitled "Additional Information on Eligibility" for clarification)

Other Eligible Applicants include the following: Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

## What the grant funds

This Funding Opportunity Announcement (FOA) invites applications for Clinical and Translational Science Awards (CTSA) Program consortium-wide resource centers that will rapidly demonstrate and disseminate to the wider consortium innovative resources (to include capabilities) that have established impact at a local or national level. Applications for CTSA consortium-wide centers are expected to rapidly demonstrate and disseminate resources to advance clinical and translational science efforts. Only applications submitted in response to a Notice of Special Interest (NOSI) published by NCATS will be allowed to apply to this FOA.

## Questions people ask

### Is PAR-22-122 still open?

No. It closed on January 6, 2023.

### Who can apply for Limited Competition: Clinical and Translational Science Awards (CTSA) Consortium-Wide Centers: Resources for Rapid Demonstration and Dissemination (U24 Clinical Trials Optional)?

National Institutes of Health accepted applications from state and local governments. The notice adds further conditions, so read its eligibility section.

### What is the deadline for Limited Competition: Clinical and Translational Science Awards (CTSA) Consortium-Wide Centers: Resources for Rapid Demonstration and Dissemination (U24 Clinical Trials Optional)?

Closed January 6, 2023. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### How much funding is available?

Awards of up to $3.0 million each.

### Who has been funded under PAR-22-122?

NIH RePORTER lists 3 projects funded under PAR-22-122 in fiscal 2023 to 2026, at 2 institutions. The most were at Vanderbilt University Medical Center, Johns Hopkins University.

### Who has won National Center for Advancing Translational Sciences grants before?

The largest recipients over five fiscal years were University of Pittsburgh - of the Commonwealth System of Higher Education, Vanderbilt University Medical Center, Duke University. The program made 867 awards worth $3.1 billion in that time.